Impact of COVID-19 Outbreak on Nasal Decongestant, Global Market Research Report 2020

July 2020 | 96 pages | ID: I5C2104DA7BCEN
QYResearch

Abstracts

This report also analyses the impact of Coronavirus COVID-19 on the Nasal Decongestant industry.
Based on our recent survey, we have several different scenarios about the Nasal Decongestant YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Nasal Decongestant will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Nasal Decongestant market is segmented into

• Nasal Strips
• Tablet
• Spray
• Capsule

Segment by Application

• Asthma
• Cold
• Nasal Allergies

Global Nasal Decongestant Market: Regional Analysis
The Nasal Decongestant market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Nasal Decongestant market report are:

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• U.A.E

Global Nasal Decongestant Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Nasal Decongestant market include:

• Abbott Laboratories
• Glaxosmithkline
• Cipla
• Bayer
• ADAPT Pharma
• Patrick Parsons
• Nidda Healthcare
• Procter and Gamble
• Rugby Laboratories

Contents

1 NASAL DECONGESTANT MARKET OVERVIEW

1.1 Product Overview and Scope of Nasal Decongestant
1.2 Covid-19 Implications on Nasal Decongestant Segment by Type
  1.2.1 Global Nasal Decongestant Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Nasal Strips
  1.2.3 Tablet
  1.2.4 Spray
  1.2.5 Capsule
1.3 Covid-19 Implications on Nasal Decongestant Segment by Application
  1.3.1 Nasal Decongestant Sales Comparison by Application: 2020 VS 2026
  1.3.2 Asthma
  1.3.3 Cold
  1.3.4 Nasal Allergies
1.4 Covid-19 Implications on Global Nasal Decongestant Market Size Estimates and Forecasts
  1.4.1 Global Nasal Decongestant Revenue 2015-2026
  1.4.2 Global Nasal Decongestant Sales 2015-2026
  1.4.3 Nasal Decongestant Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Nasal Decongestant Industry Impact
  1.5.1 How the Covid-19 is Affecting the Nasal Decongestant Industry
    1.5.1.1 Nasal Decongestant Business Impact Assessment - Covid-19
    1.5.1.2 Supply Chain Challenges
    1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.5.2 Market Trends and Nasal Decongestant Potential Opportunities in the COVID-19 Landscape
  1.5.3 Measures / Proposal against Covid-19
    1.5.3.1 Government Measures to Combat Covid-19 Impact
    1.5.3.2 Proposal for Nasal Decongestant Players to Combat Covid-19 Impact

2 COVID-19 IMPLICATIONS ON GLOBAL NASAL DECONGESTANT MARKET COMPETITION BY MANUFACTURERS

2.1 Global Nasal Decongestant Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nasal Decongestant Revenue Share by Manufacturers (2015-2020)
2.3 Global Nasal Decongestant Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nasal Decongestant Manufacturing Sites, Area Served, Product Type
2.5 Nasal Decongestant Market Competitive Situation and Trends
  2.5.1 Nasal Decongestant Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nasal Decongestant Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON NASAL DECONGESTANT RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Nasal Decongestant Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nasal Decongestant Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nasal Decongestant Market Facts & Figures by Country
  3.3.1 North America Nasal Decongestant Sales by Country
  3.3.2 North America Nasal Decongestant Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Nasal Decongestant Market Facts & Figures by Country
  3.4.1 Europe Nasal Decongestant Sales by Country
  3.4.2 Europe Nasal Decongestant Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Nasal Decongestant Market Facts & Figures by Region
  3.5.1 Asia Pacific Nasal Decongestant Sales by Region
  3.5.2 Asia Pacific Nasal Decongestant Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Nasal Decongestant Market Facts & Figures by Country
  3.6.1 Latin America Nasal Decongestant Sales by Country
  3.6.2 Latin America Nasal Decongestant Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Nasal Decongestant Market Facts & Figures by Country
  3.7.1 Middle East and Africa Nasal Decongestant Sales by Country
  3.7.2 Middle East and Africa Nasal Decongestant Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 U.A.E

4 GLOBAL NASAL DECONGESTANT HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Nasal Decongestant Sales Market Share by Type (2015-2020)
4.2 Global Nasal Decongestant Revenue Market Share by Type (2015-2020)
4.3 Global Nasal Decongestant Price Market Share by Type (2015-2020)
4.4 Global Nasal Decongestant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL NASAL DECONGESTANT HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Nasal Decongestant Sales Market Share by Application (2015-2020)
5.2 Global Nasal Decongestant Revenue Market Share by Application (2015-2020)
5.3 Global Nasal Decongestant Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN NASAL DECONGESTANT BUSINESS

6.1 Abbott Laboratories
  6.1.1 Corporation Information
  6.1.2 Abbott Laboratories Description, Business Overview and Total Revenue
  6.1.3 Abbott Laboratories Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Abbott Laboratories Products Offered
  6.1.5 Abbott Laboratories Recent Development
6.2 Glaxosmithkline
  6.2.1 Glaxosmithkline Corporation Information
  6.2.2 Glaxosmithkline Description, Business Overview and Total Revenue
  6.2.3 Glaxosmithkline Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Glaxosmithkline Products Offered
  6.2.5 Glaxosmithkline Recent Development
6.3 Cipla
  6.3.1 Cipla Corporation Information
  6.3.2 Cipla Description, Business Overview and Total Revenue
  6.3.3 Cipla Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 Cipla Products Offered
  6.3.5 Cipla Recent Development
6.4 Bayer
  6.4.1 Bayer Corporation Information
  6.4.2 Bayer Description, Business Overview and Total Revenue
  6.4.3 Bayer Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Bayer Products Offered
  6.4.5 Bayer Recent Development
6.5 ADAPT Pharma
  6.5.1 ADAPT Pharma Corporation Information
  6.5.2 ADAPT Pharma Description, Business Overview and Total Revenue
  6.5.3 ADAPT Pharma Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 ADAPT Pharma Products Offered
  6.5.5 ADAPT Pharma Recent Development
6.6 Patrick Parsons
  6.6.1 Patrick Parsons Corporation Information
  6.6.2 Patrick Parsons Description, Business Overview and Total Revenue
  6.6.3 Patrick Parsons Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Patrick Parsons Products Offered
  6.6.5 Patrick Parsons Recent Development
6.7 Nidda Healthcare
  6.6.1 Nidda Healthcare Corporation Information
  6.6.2 Nidda Healthcare Description, Business Overview and Total Revenue
  6.6.3 Nidda Healthcare Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Nidda Healthcare Products Offered
  6.7.5 Nidda Healthcare Recent Development
6.8 Procter and Gamble
  6.8.1 Procter and Gamble Corporation Information
  6.8.2 Procter and Gamble Description, Business Overview and Total Revenue
  6.8.3 Procter and Gamble Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Procter and Gamble Products Offered
  6.8.5 Procter and Gamble Recent Development
6.9 Rugby Laboratories
  6.9.1 Rugby Laboratories Corporation Information
  6.9.2 Rugby Laboratories Description, Business Overview and Total Revenue
  6.9.3 Rugby Laboratories Nasal Decongestant Sales, Revenue and Gross Margin (2015-2020)
  6.9.4 Rugby Laboratories Products Offered
  6.9.5 Rugby Laboratories Recent Development

7 NASAL DECONGESTANT MANUFACTURING COST ANALYSIS

7.1 Nasal Decongestant Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nasal Decongestant
7.4 Nasal Decongestant Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Nasal Decongestant Distributors List
8.3 Nasal Decongestant Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Nasal Decongestant Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Nasal Decongestant by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Nasal Decongestant by Type (2021-2026)
10.2 Nasal Decongestant Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Nasal Decongestant by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Nasal Decongestant by Application (2021-2026)
10.3 Nasal Decongestant Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Nasal Decongestant by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Nasal Decongestant by Region (2021-2026)
10.4 North America Nasal Decongestant Estimates and Projections (2021-2026)
10.5 Europe Nasal Decongestant Estimates and Projections (2021-2026)
10.6 Asia Pacific Nasal Decongestant Estimates and Projections (2021-2026)
10.7 Latin America Nasal Decongestant Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nasal Decongestant Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Nasal Decongestant Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nasal Decongestant Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nasal Decongestant Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Nasal Decongestant Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Nasal Decongestant Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Nasal Decongestant Players to Combat Covid-19 Impact
Table 9. Global Key Nasal Decongestant Manufacturers Covered in This Study
Table 10. Global Nasal Decongestant Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Nasal Decongestant Sales Share by Manufacturers (2015-2020)
Table 12. Global Nasal Decongestant Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Nasal Decongestant Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Nasal Decongestant Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Nasal Decongestant Sales Sites and Area Served
Table 16. Manufacturers Nasal Decongestant Product Types
Table 17. Global Nasal Decongestant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Nasal Decongestant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Decongestant as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Nasal Decongestant Players
Table 21. Global Nasal Decongestant Sales (K Units) by Region (2015-2020)
Table 22. Global Nasal Decongestant Sales Market Share by Region (2015-2020)
Table 23. Global Nasal Decongestant Revenue (Million US$) by Region (2015-2020)
Table 24. Global Nasal Decongestant Revenue Market Share by Region (2015-2020)
Table 25. North America Nasal Decongestant Sales by Country (2015-2020) (K Units)
Table 26. North America Nasal Decongestant Sales Market Share by Country (2015-2020)
Table 27. North America Nasal Decongestant Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Nasal Decongestant Revenue Market Share by Country (2015-2020)
Table 29. Europe Nasal Decongestant Sales by Country (2015-2020) (K Units)
Table 30. Europe Nasal Decongestant Sales Market Share by Country (2015-2020)
Table 31. Europe Nasal Decongestant Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Nasal Decongestant Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Nasal Decongestant Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Nasal Decongestant Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Nasal Decongestant Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Nasal Decongestant Revenue Market Share by Region (2015-2020)
Table 37. Latin America Nasal Decongestant Sales by Country (2015-2020) (K Units)
Table 38. Latin America Nasal Decongestant Sales Market Share by Country (2015-2020)
Table 39. Latin America Nasal Decongestant Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Nasal Decongestant Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Nasal Decongestant Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Nasal Decongestant Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Nasal Decongestant Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Nasal Decongestant Revenue Market Share by Country (2015-2020)
Table 45. Global Nasal Decongestant Sales (K Units) by Type (2015-2020)
Table 46. Global Nasal Decongestant Sales Share by Type (2015-2020)
Table 47. Global Nasal Decongestant Revenue (Million US$) by Type (2015-2020)
Table 48. Global Nasal Decongestant Revenue Share by Type (2015-2020)
Table 49. Global Nasal Decongestant Price (US$/Unit) by Type (2015-2020)
Table 50. Global Nasal Decongestant Sales (K Units) by Application (2015-2020)
Table 51. Global Nasal Decongestant Sales Market Share by Application (2015-2020)
Table 52. Global Nasal Decongestant Sales Growth Rate by Application (2015-2020)
Table 53. Abbott Laboratories Nasal Decongestant Corporation Information
Table 54. Abbott Laboratories Description and Business Overview
Table 55. Abbott Laboratories Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Abbott Laboratories Main Product
Table 57. Abbott Laboratories Recent Development
Table 58. Glaxosmithkline Nasal Decongestant Corporation Information
Table 59. Glaxosmithkline Corporation Information
Table 60. Glaxosmithkline Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Glaxosmithkline Main Product
Table 62. Glaxosmithkline Recent Development
Table 63. Cipla Nasal Decongestant Corporation Information
Table 64. Cipla Corporation Information
Table 65. Cipla Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Cipla Main Product
Table 67. Cipla Recent Development
Table 68. Bayer Nasal Decongestant Corporation Information
Table 69. Bayer Corporation Information
Table 70. Bayer Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Bayer Main Product
Table 72. Bayer Recent Development
Table 73. ADAPT Pharma Nasal Decongestant Corporation Information
Table 74. ADAPT Pharma Corporation Information
Table 75. ADAPT Pharma Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. ADAPT Pharma Main Product
Table 77. ADAPT Pharma Recent Development
Table 78. Patrick Parsons Nasal Decongestant Corporation Information
Table 79. Patrick Parsons Corporation Information
Table 80. Patrick Parsons Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Patrick Parsons Main Product
Table 82. Patrick Parsons Recent Development
Table 83. Nidda Healthcare Nasal Decongestant Corporation Information
Table 84. Nidda Healthcare Corporation Information
Table 85. Nidda Healthcare Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Nidda Healthcare Main Product
Table 87. Nidda Healthcare Recent Development
Table 88. Procter and Gamble Nasal Decongestant Corporation Information
Table 89. Procter and Gamble Corporation Information
Table 90. Procter and Gamble Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Procter and Gamble Main Product
Table 92. Procter and Gamble Recent Development
Table 93. Rugby Laboratories Nasal Decongestant Corporation Information
Table 94. Rugby Laboratories Corporation Information
Table 95. Rugby Laboratories Nasal Decongestant Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Rugby Laboratories Main Product
Table 97. Rugby Laboratories Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Nasal Decongestant Distributors List
Table 101. Nasal Decongestant Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Nasal Decongestant Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Nasal Decongestant Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Nasal Decongestant Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Nasal Decongestant Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Nasal Decongestant Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Nasal Decongestant Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Nasal Decongestant Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Nasal Decongestant Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Nasal Decongestant Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Nasal Decongestant Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nasal Decongestant
Figure 2. Global Nasal Decongestant Sales Market Share by Type: 2020 VS 2026
Figure 3. Nasal Strips Product Picture
Figure 4. Tablet Product Picture
Figure 5. Spray Product Picture
Figure 6. Capsule Product Picture
Figure 7. Global Nasal Decongestant Consumption Market Share by Application: 2020 VS 2026
Figure 8. Asthma
Figure 9. Cold
Figure 10. Nasal Allergies
Figure 11. Global Nasal Decongestant Market Size 2015-2026 (US$ Million)
Figure 12. Global Nasal Decongestant Sales Capacity (K Units) (2015-2026)
Figure 13. Global Nasal Decongestant Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Nasal Decongestant Sales Share by Manufacturers in 2020
Figure 15. Global Nasal Decongestant Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Nasal Decongestant Revenue in 2019
Figure 17. Nasal Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Nasal Decongestant Sales Market Share by Region (2015-2020)
Figure 19. Global Nasal Decongestant Sales Market Share by Region in 2019
Figure 20. Global Nasal Decongestant Revenue Market Share by Region (2015-2020)
Figure 21. Global Nasal Decongestant Revenue Market Share by Region in 2019
Figure 22. North America Nasal Decongestant Sales Market Share by Country in 2019
Figure 23. North America Nasal Decongestant Revenue Market Share by Country in 2019
Figure 24. U.S. Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Nasal Decongestant Sales Market Share by Country in 2019
Figure 29. Europe Nasal Decongestant Revenue Market Share by Country in 2019
Figure 30. Germany Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Nasal Decongestant Sales Market Share by Region in 2019
Figure 41. Asia Pacific Nasal Decongestant Revenue Market Share by Region in 2019
Figure 42. China Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Nasal Decongestant Sales Market Share by Country in 2019
Figure 65. Latin America Nasal Decongestant Revenue Market Share by Country in 2019
Figure 66. Mexico Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Nasal Decongestant Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Nasal Decongestant Revenue Market Share by Country in 2019
Figure 74. Turkey Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Nasal Decongestant Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Nasal Decongestant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Nasal Decongestant by Type (2015-2020)
Figure 81. Sales Market Share of Nasal Decongestant by Type in 2019
Figure 82. Revenue Share of Nasal Decongestant by Type (2015-2020)
Figure 83. Revenue Market Share of Nasal Decongestant by Type in 2019
Figure 84. Global Nasal Decongestant Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Nasal Decongestant Sales Market Share by Application (2015-2020)
Figure 86. Global Nasal Decongestant Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Nasal Decongestant by Application (2015-2020)
Figure 88. Global Revenue Share of Nasal Decongestant by Application in 2020
Figure 89. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Glaxosmithkline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. ADAPT Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Patrick Parsons Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Nidda Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Procter and Gamble Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Rugby Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Nasal Decongestant
Figure 100. Manufacturing Process Analysis of Nasal Decongestant
Figure 101. Nasal Decongestant Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Nasal Decongestant Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Nasal Decongestant Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Nasal Decongestant Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Nasal Decongestant Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Nasal Decongestant Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Nasal Decongestant Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Nasal Decongestant Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Nasal Decongestant Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Nasal Decongestant Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Nasal Decongestant Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed